pfizer glp-1 drug Safety worries spur to drop another obesity pill Pfizer CEO vows company will

GLP-1 generics enter the worlds diabetes capital and are added to bridal packages to cut food noise

Drugs like semaglutide and liraglutide have recently gained massive attention not just for diabetes, but for weight loss

The Mark Cuban Cost Plus Drug Company has entered into a new partnership with the aim of making obesity medications affordable for self-insured employers

Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

GLP-1 medications interact with certain drugs, supplements, and substances that may reduce efficacy or increase side effects